Highlights Gubra A/S

Equities

GUBRA

DK0062266474

Real-time Estimate Cboe Europe Other stock markets 04:38:32 2024-05-13 am EDT			5-day change	1st Jan Change
330 ^DKK	-2.37%		+9.33%	+162.40%

Apr. 17	Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss	CI
Mar. 29	Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss	Apr. 17	CI
Gubra Concludes the Research Agreement with Silence Therapeutics plc	Jan. 26	CI
Gubra and Boehringer Ingelheim Sign 4Th Partnership, Expanding Their Successful Obesity Treatment Discovery Collaboration	Dec. 13	CI
Gubra A/S Announces First Subject Dosed in Phase 1 Clinical Trial of Amylin Agonist for the Treatment of Obesity	Nov. 29	CI
Gubra Raises Earnings Guidance for Full-Year 2023	23-10-26	CI
Denmark's Gubra Opens First US Office Under Expansion Strategy	23-10-24	MT
Gubra A/S Opens Its First US Office in Boston	23-10-24	CI
Gubra Seeks UK Regulatory Approval to Begin Human Trial for Anti-Obesity Drug	23-09-06	MT
Gubra A/S Submits Clinical Trial Application for First-In-Human Amylin Trial	23-09-06	CI
Tranche Update on Gubra A/S's Equity Buyback Plan announced on June 30, 2023.	23-08-25	CI
Gubra Announces Termination of Collaboration with Bayer AG	23-08-23	CI
Gubra A/S Raises Financial Guidance for Full-Year 2023	23-08-15	CI
Gubra A/S commences an Equity Buyback Plan for 1,180,424 shares, under the authorization approved on March 16, 2023.	23-06-30	CI
Gubra A/S acquired Minigut Aps for DKK 5.96 million.	23-06-28	CI
Gubra A/S Announces Updates to Its Pipeline	23-06-09	CI
Gubra A/S and Boehringer Ingelheim Share Phase 1 Results for BI 1820237	23-05-17	CI
Gubra A/S Provides Revenue Guidance for the Year 2023	23-05-11	CI
Danish Biotech Gubra's IPO Overallotment Option Partly Exercised	23-05-02	MT
Gubra A/S has completed an IPO in the amount of DKK 500.00005 million.	23-03-30	CI
Gubra A/S has filed an IPO in the amount of DKK 500.00005 million.	23-03-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Gubra A/S

Equities

GUBRA

DK0062266474

Highlights

Filters